Kwang Hooi Tan
Chief Operating Officer bei FLEX LTD.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Kwang Hooi Tan is currently the Chairman at Flextronics Industrial (Zhuhai) Co., Ltd.
since 2019 and the President-Global Operations & Components at Flex Ltd.
since 2022.
He completed his undergraduate degree at Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FLEX LTD.
0,04% | 13.03.2024 | 159 718 ( 0,04% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Kwang Hooi Tan
| Unternehmen | Position | Beginn |
|---|---|---|
| FLEX LTD. | Chief Operating Officer | - |
Flextronics Industrial (Zhuhai) Co., Ltd.
 Flextronics Industrial (Zhuhai) Co., Ltd. Medical SpecialtiesHealth Technology Part of Lingyi iTech (Guangdong) Co., Flextronics Industrial (Zhuhai) Co., Ltd. is a Chinese company that manufactures optical lens. The private company is based in Zhuhai, China. The company was founded in 1999. Flextronics Industrial (Zhuhai) Co. was acquired by Shenzhen Lingyi Technology Development Co., Ltd. from Flex Ltd. on January 07, 2021 for $58.75 million. | Chairman | 20.12.2019 |
Ausbildung von Kwang Hooi Tan
| Purdue University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FLEX LTD. | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
Flextronics Industrial (Zhuhai) Co., Ltd.
Flextronics Industrial (Zhuhai) Co., Ltd. Medical SpecialtiesHealth Technology Part of Lingyi iTech (Guangdong) Co., Flextronics Industrial (Zhuhai) Co., Ltd. is a Chinese company that manufactures optical lens. The private company is based in Zhuhai, China. The company was founded in 1999. Flextronics Industrial (Zhuhai) Co. was acquired by Shenzhen Lingyi Technology Development Co., Ltd. from Flex Ltd. on January 07, 2021 for $58.75 million. | Health Technology |
